atorvastatin has been researched along with stilbenes in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fu, LC; Gao, X; Hu, YJ | 1 |
Bansal, SS; Ferrari, M; Ferrati, S; Filipini, S; Filippini, S; Fine, D; Grattoni, A; Nicolov, E; Palapattu, G; Raghuwansi, K; Sih, J; Zabre, E | 1 |
Berbée, JF; Havekes, LM; Hiemstra, PS; Khedoe, PP; Mol, IM; Princen, HM; Rensen, PC; Romijn, JA; Tsikas, D; van der Hoorn, JW; van Klinken, JB; Wang, Y; Wong, MC | 1 |
Dinesh, N; Kaur, PK; Kishore Babu, N; Pallerla, DS; Singh, S | 1 |
4 other study(ies) available for atorvastatin and stilbenes
Article | Year |
---|---|
[Blood lipid-regulation of stilbene glycoside from polygonum multiflorum].
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Glucosides; Hepatocytes; Heptanoic Acids; Hydroxymethylglutaryl CoA Reductases; Hyperlipidemias; Male; Plant Tubers; Plants, Medicinal; Polygonum; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, LDL; RNA, Messenger; Stilbenes; Triglycerides | 2007 |
Characterization of nanochannel delivery membrane systems for the sustained release of resveratrol and atorvastatin: new perspectives on promoting heart health.
Topics: Anticholesteremic Agents; Atorvastatin; Cell Line; Cell Survival; Diffusion; Drug Delivery Systems; Drug Implants; Equipment Design; Heptanoic Acids; Humans; Membranes, Artificial; Nanostructures; Pyrroles; Resveratrol; Stilbenes; Vasodilator Agents | 2013 |
Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.
Topics: Animals; Atherosclerosis; Atorvastatin; Biomarkers; Cholesterol, Dietary; Cholesterol, LDL; Drug Synergism; Female; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Mice; Mice, Transgenic; Oxidative Stress; Pyrroles; Resveratrol; Stilbenes | 2013 |
Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies.
Topics: Amino Acid Sequence; Atorvastatin; Cholesterol; Cloning, Molecular; DNA, Protozoan; Drug Delivery Systems; Ergosterol; Gene Expression Regulation, Enzymologic; Genes, Protozoan; Heptanoic Acids; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leishmania donovani; Molecular Sequence Data; Open Reading Frames; Protein Structure, Secondary; Pyrroles; Recombinant Proteins; Resveratrol; Sequence Analysis, DNA; Simvastatin; Stilbenes | 2014 |